Medesis Pharma SA (ALMDP.PA) Stock Analyst Ratings

EPA:ALMDP • FR0010844464

0.35 EUR
-0.03 (-8.14%)
Last: Mar 10, 2025, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Buy % Consensus

40

ChartMill assigns a Buy % Consensus number of 40% to ALMDP.PA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 0.82. This target is 133.14% above the current price.
  • ALMDP.PA was analyzed by 7 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about ALMDP.PA.
  • In the previous month the buy percentage consensus was at a similar level.
  • ALMDP.PA was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
ALMDP.PA Historical Analyst RatingsALMDP.PA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Price Target & Forecast

Price Low Median Mean High 0.350.810.820.820.84 - 130.86% 133.14% 133.14% 140.00%

Related screens

Find peers 30% below price target
ALMDP.PA Current Analyst RatingALMDP.PA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades

Medesis Pharma SA / ALMDP.PA FAQ

What do analysts expect the price target to be for Medesis Pharma SA (ALMDP.PA)?

7 analysts have analysed ALMDP.PA and the average price target is 0.82 EUR. This implies a price increase of 133.14% is expected in the next year compared to the current price of 0.35.


What is the consensus rating for ALMDP stock?

The consensus rating for Medesis Pharma SA (ALMDP.PA) is 40 / 100 . This indicates that analysts generally have a neutral outlook on the stock.